An orally available, small-molecule interferon inhibits viral replication.
An orally available, small-molecule interferon inhibits viral replication.
复制标题
DOI:
10.1038/srep00259
复制
发表时间:
2012
影响因子:
4.6
通讯作者:
Sudoh, Masayuki
中科院分区:
文献类型:
--
作者:
Konishi, Hideyuki;Okamoto, Koichi;Ohmori, Yusuke;Yoshino, Hitoshi;Ohmori, Hiroshi;Ashihara, Motooki;Hirata, Yuichi;Ohta, Atsunori;Sakamoto, Hiroshi;Hada, Natsuko;Katsume, Asao;Kohara, Michinori;Morikawa, Kazumi;Tsukuda, Takuo;Shimma, Nobuo;Foster, Graham R.;Alazawi, William;Aoki, Yuko;Arisawa, Mikio;Sudoh, Masayuki
Most acute hepatitis C virus (HCV) infections become chronic and some progress to liver cirrhosis or hepatocellular carcinoma. Standard therapy involves an interferon (IFN)-α-based regimen, and efficacy of therapy has been significantly improved by the development of protease inhibitors. However, several issues remain concerning the injectable form and the side effects of IFN. Here, we report an orally available, small-molecule type I IFN receptor agonist that directly transduces the IFN signal cascade and stimulates antiviral gene expression. Like type I IFN, the small-molecule compound induces IFN-stimulated gene (ISG) expression for antiviral activity in vitro and in vivo in mice, and the ISG induction mechanism is attributed to a direct interaction between the compound and IFN-α receptor 2, a key molecule of IFN-signaling on the cell surface. Our study highlights the importance of an orally active IFN-like agent, both as a therapy for antiviral infections and as a potential IFN substitute.
登录
查看更多内容
影响因子:
3.7
作者:
Farnsworth A;Flaman AS;Prasad SS;Gravel C;Williams A;Yauk CL;Li X
通讯作者:
Li X
影响因子:
64.8
作者:
Hemmi, H;Takeuchi, O;Akira, S
通讯作者:
Akira, S
影响因子:
158.5
作者:
Jacobson, Ira M.;McHutchison, John G.;Zeuzem, Stefan
通讯作者:
Zeuzem, Stefan
DOI:
10.1196/annals.1443.020
发表时间:
2008-01-01
期刊:
YEAR IN IMMUNOLOGY 2008
影响因子:
--
作者:
Kawai, Taro;Akira, Shizuo
通讯作者:
Akira, Shizuo
影响因子:
82.9
作者:
Mercer, DF;Schiller, DE;Kneteman, NM
通讯作者:
Kneteman, NM